
A trio of nephrology experts discuss the significance of iptacopan’s FDA approval as the first treatment for C3G.

Jared Hassler, MD, is a pathologist at the Temple University Hospital.

A trio of nephrology experts discuss the significance of iptacopan’s FDA approval as the first treatment for C3G.